FRONTONI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 1.927
EU - Europa 563
AS - Asia 301
SA - Sud America 11
AF - Africa 5
OC - Oceania 5
Totale 2.812
Nazione #
US - Stati Uniti d'America 1.915
IT - Italia 194
SG - Singapore 115
IN - India 108
UA - Ucraina 101
SE - Svezia 88
CN - Cina 68
FI - Finlandia 55
DE - Germania 54
AT - Austria 20
CA - Canada 11
AR - Argentina 10
GB - Regno Unito 10
BG - Bulgaria 8
RU - Federazione Russa 8
IE - Irlanda 7
ID - Indonesia 5
RO - Romania 4
TG - Togo 4
AU - Australia 3
BE - Belgio 2
CH - Svizzera 2
FR - Francia 2
KR - Corea 2
NL - Olanda 2
NZ - Nuova Zelanda 2
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
GR - Grecia 1
IR - Iran 1
LT - Lituania 1
MK - Macedonia 1
MX - Messico 1
PL - Polonia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 2.812
Città #
Fairfield 327
Woodbridge 166
Chandler 155
Ashburn 154
Houston 127
Seattle 106
Cambridge 89
Wilmington 83
Ann Arbor 82
Singapore 75
Rome 67
Princeton 53
Plano 46
Jacksonville 42
Dearborn 35
Boston 33
Beijing 32
San Paolo di Civitate 31
Lawrence 27
Santa Clara 25
Des Moines 24
Grafing 20
Millbury 17
Vienna 17
San Diego 15
Helsinki 12
Andover 11
Munich 11
New York 11
Norwalk 10
Federal 9
Sofia 8
Boardman 7
Dublin 7
Falls Church 7
Toronto 7
Milan 6
Fasano 5
Hefei 5
Jakarta 5
Mannheim 5
Fremont 4
Lomé 4
Los Angeles 4
Nanjing 4
Venezia 4
Chapel Hill 3
Dallas 3
Genzano 3
Lidköping 3
Moscow 3
Ottawa 3
Bari 2
Bern 2
Brussels 2
Bühl 2
Castelnuovo del Garda 2
Conegliano 2
Foggia 2
Lappeenranta 2
Laurel 2
London 2
Modugno 2
Naples 2
Napoli 2
Padova 2
Philadelphia 2
Porto Recanati 2
San Mateo 2
Simi Valley 2
Tower Hamlets 2
Venice 2
Algiers 1
Amsterdam 1
Atlanta 1
Auckland 1
Bolzano Vicentino 1
Bonndorf 1
Bratislava 1
Bucharest 1
Buffalo 1
Catanzaro 1
Cernobbio 1
Changchun 1
Collegno 1
Coominya 1
Copenhagen 1
Cutrofiano 1
Edinburgh 1
Elk Grove 1
Ercolano 1
Falkenstein 1
Ferrara 1
Fuzhou 1
Gandhi Nagar 1
Gelsenkirchen 1
Giarre 1
Guangzhou 1
Gunzenhausen 1
Hengyang 1
Totale 2.080
Nome #
A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis 113
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS 108
Ballismo, atetosi e discinesie parossistiche 102
Dynamic changes of mmp-9 plasma levels correlate with jvc reactivation and immune activation in natalizumab-treated multiple sclerosis patients 94
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study 84
Drug holiday of interferon beta 1b in multiple sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority 82
Ultrasonographic evaluation of cerebral arterial and venous haemodynamics in multiple sclerosis: a case-control study. 79
MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosis. 78
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis 78
Parkinson's disease related pain: a review of recent findings. 75
Power spectrum analysis contribution to the detection of cardiovascular dysautonomia in multiple sclerosis. 74
Can the Expanded Disability Status Scale be assessed by telephone? 73
Cost minimization analysis of BoNT-As in the treatment of upper limb spasticity and cervical dystonia 73
Reversed laterality of cerebral functions in a non-right-hander: neuropsychological and spect findings in a case of 'atypical' dominance. 70
Interferon beta treatment of MS in the daily clinical setting: a 3-year post-marketing study 70
Photophobia in multiple sclerosis 69
Early fibrinolysis and brain protection: design of a four-arm clinical trial in brain infarction. 66
Fatigue in Parkinson's disease: Motor or non-motor symptom? 65
JC virus-DNA detection is associated with CD8 fffector accumulation in peripheral blood of patients with multiple sclerosis under natalizumab treatment, independently from JC virus serostatus 65
Thrombolysis in acute ischemic stroke 62
Effect of stress on cardiovascular regulation in neurological diseases with dysautonomia. 62
MAGNETIC RESONANCE IMAGING OUTCOME OF NEW ENHANCING LESIONS IN RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS TREATED WITH INTERFERON-B1A 60
Cardiac autonomic dysfunction in relapsing-remitting multiple sclerosis during a stable phase 60
Invasive treatment of acute stroke. 58
Power spectrum analysis contribution to the detection of cardiovascular dysautonomia in multiple sclerosis. 56
MRI in multiple sclerosis during the menstrual cycle: Relationship with sex hormone patterns 56
Update on calcium antagonists in cerebrovascular diseases. 55
Early diagnosis of secondary progressive multiple sclerosis: focus on fluid and neurophysiological biomarkers 53
AUTONOMIC DYSFUNCTION IN MULTIPLE SCLEROSIS 52
Determinants of Gd-enhanced MRI response to IFN-beta-I a treatment in relapsing-remitting multiple sclerosis 52
Pharmacological approach to acute ischemic stroke 52
INVASIVE TREATMENT OF ACUTE STROKE 52
Treatment of Acute Ischemic Stroke 49
Malattie cerebrovascolari. 48
Cardiac autonomic dysfunction in patients with alzheimer's disease: possible pathogenetic mechanisms. 48
Autonomic dysfunction in MS 47
Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study 46
POWER SPECTRUM ANALYSIS CONTRIBUTION TO THE DETECTION OF CARDIOVASCULAR DYSAUTONOMIA IN MULTIPLE SCLEROSIS 45
No increase of serum autoantibodies during therapy with recombinant human interferon-beta1a in relapsing-remitting multiple sclerosis. 44
Malattie cerebrovascolari 44
Does hyperglicemia play a role on the outcome of acute ischemic stroke patients? 42
NO INCREASE OF SERUM ANTIBODIES DURING THERAPY WITH RECOMBINANT HUMAN INTERFERON-B1A IN RELAPSING-REMITTING MULTIPLE SCLEROSIS 35
Chronic Cerebro-Spinal Venous Insufficiency is not significantly associated to Relapsing-Remitting Multiple Sclerosis. 35
Correlations between sexual hormones and disease activity on MRI in multiple sclerosis 34
Magnetic resonance disease activity in multiple sclerosis (MS): correlation with menstrual cycle phase and hormonal parameters 33
Controlled clinical trials in stroke. 30
Malignant gastric carcinoid and paraneoplastic cerebellar degeneration 20
What are we learning form clinical trials in acute cerebral ischemia? 19
Evaluation of medical treatment in acute ischemic stroke 17
Magnetic resonance imaging outcome of new enhancing lesions in relapsing-remitting multiple sclerosis patients treated with interferon beta1a. 15
Totale 2.899
Categoria #
all - tutte 8.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.053


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020446 0 0 0 0 0 97 85 85 70 61 34 14
2020/2021251 29 23 10 18 4 24 3 23 21 69 20 7
2021/2022506 3 20 36 25 72 14 18 44 43 33 86 112
2022/2023539 98 106 42 40 58 68 5 34 56 5 16 11
2023/2024224 11 40 3 18 15 25 1 29 0 26 32 24
2024/2025158 19 29 20 31 27 32 0 0 0 0 0 0
Totale 2.899